Cancer is a terrifying diagnosis. The second-leading cause of death in the United States drains $25 trillion a year from the ...

Colossal, a leading biosciences company working to combat environmental dangers and revive extinct species, has reached a new milestone.

Colossal Biosciences, the world’s first de-extinction company, has today announced $200M in a Series C financing by TWG ...

Touchlight, an innovation-driven Contract Development and Manufacturing Organisation (CDMO), today announced that its facility in Hampton UK has received GMP certification. As a result, Touchlight ...

The versatility of induced pluripotent stem cells in regenerative medicine, disease modeling, drug discovery, and personalized therapy underpins their growing demand. Additionally, advancements in ...

Gen Biomanufacturing InitiativesDublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Induced Pluripotent Stem Cell (iPSC) Industry Report - Market Size, Trends, & Forecasts, 2025" report has been added to ...

Gene editing involves precise changes in DNA sequences using enzymes, revolutionizing medical, agricultural, and research ...

To eliminate these roadblocks, BioV has launched a first-of-its-kind international collaboration platform that connects research institutions, medical organizations, and tech companies across the ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

Genome editing with CRISPR-Cas is often associated with the induction of mutations. However, a team of researchers from the ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

Biochemist Jennifer Doudna, a faculty scientist at the Department of Energy’s Lawrence Berkeley National Laboratory, founder ...